Search Results

An Ozempic pen used for the treatment of diabetes.
MBT Desk
3 min read
The timing of the last dose of GLP-1 agonist like Ozempic can influence anesthesia-related complications
GLP-1 Receptor Agonist Shortage Causes Severe Problems for Diabetes Patients (Representational image: Unsplash )
MBT Desk
5 min read
Use of GLP-1 Receptor Agonists for Weight Loss Leads to Shortages for Diabetes Patients
An image of the building of the headquarters of WHO.
MBT Desk
2 min read
WHO expands access by including immunotherapies and GLP-1 agonists in its EML for broader global health equity.
An image of Page Campbell in an orange robe sitting on a hospital bed.
MBT Desk
6 min read
Many gained access to GLP-1s through Medicaid’s decision in late 2024 to cover these weight loss drugs. But these medications remain out of reach for millions of patients across the US.
Scientist working in a laboratory setting.
MBT Desk
3 min read
The authors note that in conversations with physicians, they encountered hesitancy in prescribing GLP-1 therapies to BBS patients.
A recent study in GLP-1 drugs potentially improved surgical complications and recovery in diabetes patients (Representational Image: Pexels)
Dr. Disha Merlyn Mathias
3 min read
A possibility for improving surgical complications in diabetic patients
Read More
logo
Medbound Times
www.medboundtimes.com